Balloon valvuloplasty is used to treat aortic valve stenosis (narrowing). This condition may be congenital, or it may develop later in life as a result of rheumatic fever or calcium build-up on the ...

Congenital heart defects are the most common type of birth defect and include critical pulmonary stenosis, pulmonary atresia with a ventricular septal defect and pulmonary atresia with intact ...

Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced its next-generation balloon-expandable valve has received approval from the FDA ...

The procedure successfully reduced the peak gradient across the aortic valve by 50% or more in 73 (68%) neonates and young infants, with a mean relative gradient reduction of 54 ± 26% in the short ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Balloon-expandable transcatheter aortic valves were associated with less paravalvular ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of biomimetic heart ...

Washington, D.C. – MAY 2, 2025 – New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, effective, and resulted in shorter ...

SAN DIEGO, CA—In patients at high risk for surgery who undergo TAVR, self-expanding and balloon expandable devices are associated with similar safety at 30 days, with no differences between procedures ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Balloon rupture during transcatheter aortic valve replacement (TAVR) is a rare but serious complication.